Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-04

Clinical Trial Update: Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial conducted by Dexa Medica Group evaluated the efficacy and safety of DLBS1033 in adults with Type 2 Diabetes Mellitus; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DLBS1033 (DLBS1033)

Snippet

Sponsor: Dexa Medica Group | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED